Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Esophagitis

imatinib mesylate has been researched along with Esophagitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, S; Ichiba, M; Nakabori, T; Shibuya, M; Yamamoto, K1
Astorino, M; Azzaroli, F; Biasco, G; Catena, F; Di Battista, M; Di Scioscio, V; Lolli, C; Maleddu, A; Pantaleo, MA; Santini, D; Saponara, M1

Other Studies

2 other study(ies) available for imatinib mesylate and Esophagitis

ArticleYear
[A case of exfoliative esophagitis caused by endoscopic submucosal dissection during imatinib treatment for gastrointestinal stromal tumor].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013, Volume: 110, Issue:4

    Topics: Aged; Antineoplastic Agents; Benzamides; Endoscopy; Esophagitis; Female; Gastric Mucosa; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Pyrimidines

2013
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib.
    Endoscopy, 2009, Volume: 41 Suppl 2

    Topics: Benzamides; Biopsy, Needle; Chemotherapy, Adjuvant; Esophagitis; Esophagoscopy; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Piperazines; Pyrimidines; Risk Assessment; Severity of Illness Index; Stomach Neoplasms; Tomography, X-Ray Computed

2009